17 October 2020 : Case report
Rare Human Epidermal Growth Factor Receptor 2 (HER-2)-Positive Neuroendocrine Carcinoma of the Breast: A Case Report with 9-Year Follow-up
Rare disease
DOI: 10.12659/AJCR.925895
Am J Case Rep 2020; 21:e925895
Related articles
08 Oct 2018 : Laboratory Research
Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients’ Clinical Features
Wei Li, Youquan Wang
DOI: 10.12659/MSM.911640
Med Sci Monit 2018; 24: LBR7178-7185
20 Aug 2018 : Laboratory Research
Lapatinib, a Dual Inhibitor of Epidermal Growth Factor Receptor (EGFR) and HER-2, Enhances Radiosensitivity in Mouse Bladder Tumor Line-2 (MBT-2) Cells In Vitro and In Vivo
Yi Mu, Deyu Sun
DOI: 10.12659/MSM.909865
Med Sci Monit 2018; 24: LBR5811-5819
23 Dec 2016 : Animal Research
Effect of Fu-Zheng-Xiao-Liu Granules on Expression of Human Epidermal Growth Factor Receptor 2 (HER-2) and Proliferation and Apoptosis of Breast Cancer Cell Line SKBR-3
Ting Mo, Shuangbing Yue
DOI: 10.12659/MSM.898685
Med Sci Monit 2016; 22:5068-5073
In Press
14 Mar 2024 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.942770
16 Mar 2024 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.943214
16 Mar 2024 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.943010
16 Mar 2024 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.943687
Most Viewed Current Articles
07 Mar 2024 : Case report 
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report 
DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250